PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 4, 2016Analytical and Bioanalytical Chemistry301 citationsOpen Access

Raman spectroscopy as a process analytical technology for pharmaceutical manufacturing and bioprocessing

KEKaren A. Esmonde‐WhiteMCMaryann CuellarCUCarsten Uerpmann

Key Points

Key points are not available for this paper at this time.

Abstract

Adoption of Quality by Design (QbD) principles, regulatory support of QbD, process analytical technology (PAT), and continuous manufacturing are major factors effecting new approaches to pharmaceutical manufacturing and bioprocessing. In this review, we highlight new technology developments, data analysis models, and applications of Raman spectroscopy, which have expanded the scope of Raman spectroscopy as a process analytical technology. Emerging technologies such as transmission and enhanced reflection Raman, and new approaches to using available technologies, expand the scope of Raman spectroscopy in pharmaceutical manufacturing, and now Raman spectroscopy is successfully integrated into real-time release testing, continuous manufacturing, and statistical process control. Since the last major review of Raman as a pharmaceutical PAT in 2010, many new Raman applications in bioprocessing have emerged. Exciting reports of in situ Raman spectroscopy in bioprocesses complement a growing scientific field of biological and biomedical Raman spectroscopy. Raman spectroscopy has made a positive impact as a process analytical and control tool for pharmaceutical manufacturing and bioprocessing, with demonstrated scientific and financial benefits throughout a product's lifecycle.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Esmonde‐White et al. (2016) studied this question.

synapsesocial.com/papers/69dbc60d3d9adb00e7684fe6https://doi.org/10.1007/s00216-016-9824-1
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Quality by Design Approaches to Formulation Robustness—An Antibody Case Study2016 · 17 citations
  2. 2Reference database of Raman spectra of pharmaceutical excipients2008 · 230 citations
  3. 32014: The PAT Trend Is Still Bullish2015 · 7 citations
  4. 4Monitoring cell culture media degradation using surface enhanced Raman scattering (SERS) spectroscopy2014 · 43 citations
  5. 5Autofluorescence of viable cultured mammalian cells.1979 · 559 citations